Insider Trading History of Korenberg Matthew E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Korenberg Matthew E since year 2005. The trader's CIK number is 1649903. At the time of the last reporting, Korenberg Matthew E was the EVP,Finance & Strategy and CFO of Ligand Pharmaceuticals Inc . (stock ticker symbol LGND). See this page for all insider trading activities at Ligand Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Korenberg Matthew E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-09-03 LGND Ligand Pharmaceuticals Inc Buy 500 86.18 43,091
2018-08-29 LGND Ligand Pharmaceuticals Inc Option Ex 11,540 85.79 990,016
2018-08-29 LGND Ligand Pharmaceuticals Inc Sale 18,357 256.69 4,712,058
2017-11-17 LGND Ligand Pharmaceuticals Inc Sale 6,559 142.63 935,510

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Korenberg Matthew E (EVP,Finance & Strategy and CFO of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month